Pfizer Inc
NYSE: PFE
$29.35
+$0.04 (+0.1%)
Real Time Data Delayed 15 Min.
PFE Articles
thinkstockMarch 21, 2014: Markets opened higher on Friday but the Nasdaq sank quickly, bounced for a while, and finally settled solidly lower. It took the Dow and the S&P 500 until noon to really...
Published:
Last Updated:
After a rocky week where the markets were concerned about everything from Russia, slowing Chinese growth and why Malaysia Airlines Flight 370 can’t be found, some investors have started to move...
Published:
Last Updated:
In a new report out from Jefferies, the analysts posted a complete list of the cheapest, on a P/E basis, of the top health care stocks to buy now. Investors concerned about the toppy market may want...
Published:
Wikimedia CommonsShares of drug maker Pfizer Inc. (NYSE: PFE) were halted Wednesday afternoon at $32.29, down about 0.4% from the opening price. The company announced that its patent infringement...
Published:
Last Updated:
ThinkstockThe short interest data for the final two weeks of February is out, and the results are somewhat surprising when it comes to the top high-yield safe dividends out there. Some of the changes...
Published:
In a new research report, Cowen analysts posted a list of some of the top new datapoints cited at the Cowen 2014 Healthcare Conference by large cap pharmaceutical companies concerning upcoming events...
Published:
thinkstockMarch 6, 2014: Markets opened higher on Thursday after an encouraging report on new claims for jobless benefits, an improvement (for workers) in unit labor costs, and a decline in factory...
Published:
Last Updated:
Merrill Lynch likes the health care sector and has made no secret that they think that it can continue to outperform for the balance of 2014. Here are some of the top health care names to buy now...
Published:
thinkstockFebruary 5, 2014: Markets opened lower on Wednesday following the report from ADP that nonfarm payrolls had risen less than expected in January. And unlike yesterday, the Japanese yen...
Published:
Last Updated:
Before the markets opened Wednesday morning, drug giant Merck & Co. reported fourth-quarter and full-year 2013 results that failed to dazzle. But shares traded higher in the premarket session.
Published:
Last Updated:
thinkstockFebruary 4, 2014: Markets opened higher on Tuesday following a crushing on Monday that saw all three major indexes put up at least a 2% loss on the day. Equities got some help from a weaker...
Published:
Last Updated:
These are the top analyst upgrades, downgrades and initiations seen from Wall Street research firms on Tuesday, February 4, 2014. They include Chevron, Gap, Merck, Microsoft and Zynga.
Published:
These are the top analyst upgrades, downgrades and initiations seen from Wall Street research firms on Wednesday, January 29, 2014. They include American Airlines, Electronic Arts, VMware, Walmart...
Published:
thinkstockJanuary 28, 2014: Markets opened mixed on Tuesday, with the Nasdaq trailing at the opening bell as shares in Apple sold off following last night’s earnings report. Today’s economic data...
Published:
Last Updated:
Pfizer has managed to handily beat consensus fourth-quarter earnings expectations, at least on the surface. It also offered guidance for 2014 in line with consensus estimates.
Published: